• Publications
  • Influence
Somatostatin analogue phase I trials in neuroendocrine neoplasms.
To further investigate the antineoplastic efficacy and safety of somatostatin analogues, 2 trials were performed. Octreotide, SMS 201-995 (Sandostatin), was escalated in doses ranging from 1,500Expand
  • 103
  • 6
Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment.
  • 176
  • 3
Bioavailability of low-dose oral etoposide.
PURPOSE To determine the bioavailability of oral etoposide capsules administered at doses of 100 mg and 400 mg. PATIENTS AND METHODS The bioavailability of oral etoposide was determined byExpand
  • 141
  • 1
Inter- and intrapatient variability in etoposide kinetics with oral and intravenous drug administration.
The objective of this study was to accurately determine the within- and between-patient variability in etoposide pharmacokinetics for i.v. and p.o. administered drug. Inter-and intrapatientExpand
  • 53
  • 1
  • PDF
Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial.
In a study of the antiemetic effectiveness of high-dose oral metoclopramide, 66 previously untreated patients receiving 60 mg/m2 cisplatin were entered into a double-blind randomized trial. PatientsExpand
  • 27
High dose megestrol acetate does not alter etoposide clearance
Clinical Pharmacology & Therapeutics (1996) 59, 199–199; doi: 10.1038/sj.clpt.1996.294